A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)

NCT02070289 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-06372865
DRUG: Placebo
DRUG: PF-06372865
DRUG: Placebo
DRUG: PF-06372865
DRUG: Placebo
DRUG: PF-06372865
DRUG: Placebo
DRUG: PF-06372865
DRUG: Placebo
DRUG: PF-06372865

Sponsor

Pfizer